Evidence map›Paper›PMID 41309254›Full record

ReviewZhongguo fei ai za zhi = Chinese journal of lung cancer2025

[A Case of Combined Small Cell Lung Cancer and Literature Review].

Minglang Gao, Xiao Lu, Bo Hao, Ning Li, Songping Xie

Abstract readCase ReportsReviewEnglish Abstract
PubMed Full text at PMC Publisher
In one paragraph

Review in Zhongguo fei ai za zhi = Chinese journal of lung cancer, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Minglang GaoDepartment of Thoracic Surgery, Renmin Hospital of Wuhan University, Wuhan 430060, China.
Xiao LuDepartment of Thoracic Surgery, Renmin Hospital of Wuhan University, Wuhan 430060, China.
Bo HaoDepartment of Thoracic Surgery, Renmin Hospital of Wuhan University, Wuhan 430060, China.
Ning LiDepartment of Thoracic Surgery, Renmin Hospital of Wuhan University, Wuhan 430060, China.
Songping XieDepartment of Thoracic Surgery, Renmin Hospital of Wuhan University, Wuhan 430060, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Combined small cell lung cancer (CSCLC) is a cancer that mixes small cell lung cancer (SCLC) with non-small cell lung cancer (NSCLC) components according to the World Health Organization's 2015 New Pathologic Classification of Lung Cancer. Composed of a mixture of SCLC and NSCLC components, CSCLC is classified as a subtype of SCLC in neuroendocrine tumors. Currently, research on SCLC mainly focuses on single-component pure SCLC, with relatively few studies on CSCLC, which is clinically rare and has no standardized treatment protocols and lacks a unified perception of the clinicopathological features and prognostic predictive indexes of CSCLC. Further observation of efficacy and prognosis is needed. We report the treatment course of a case of CSCLC and provide a literature review of the current status of research on CSCLC.
.

Indexed as

Lung NeoplasmsSmall Cell Lung CarcinomaHumansMaleMiddle AgedCase reportCombined small cell lung cancerLiterature reviewLung neoplasmsSquamous cell carcinoma

Identifiers

PMID41309254
PMCPMC12666409

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.